-
Covid-19: Keeping up with the supply chain
expresspharma
March 30, 2020
Under the aegis of Ministry of Consumer Affairs, Food and Public Distribution, the Department of Consumer Affairs had issued an order to regulate the production, quality ...
-
COVID-19: ‘Army’ of volunteers join NHS as BMS postpones new study starts
pharmatimes
March 27, 2020
After the government put out a “call to arms” for new NHS volunteers to help vulnerable people to stay safe and at home, a “staggering” 405,724 people ...
-
Roche response to COVID-19 pandemic
worldpharmanews
March 27, 2020
Roche Group, provided an update on the various actions the company is taking to address the COVID-19 pandemic.
-
Amgen and the Amgen Foundation commit up to $12.5 million to support COVID-19 relief efforts
worldpharmanews
March 27, 2020
Amgen and the Amgen Foundation announced an initial commitment of up to $12.5 million to support U.S. and global relief efforts to address critical needs in communities impacted by the COVID-19 pandemic.
-
Novartis, Life Sciences Companies Commit Assets to COVID-19 Pandemic with Bill & Melinda Gates Foundation
americanpharmaceuticalreview
March 27, 2020
Novartis and a consortium of life sciences companies announced a collaboration to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19 in response to the pandemic.
-
C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment
C2 PHARMA
March 27, 2020
C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of the active pharmaceutical ingredient (API), Digoxin.
-
Mologic, Partners Begin Validation Process for COVID-19 Point-of-Need Diagnostic Test
americanpharmaceuticalreview
March 27, 2020
Mologic has initiated early validation of COVID-19 point-of-need diagnostic tests with the Liverpool School of Tropical Medicine and St Georges’ University London.
-
Indian government ceases exports of Ipca (hydroxychloroquine)
europeanpharmaceuticalreview
March 27, 2020
India has stopped exporting the malaria drug Ipca (hydroxychloroquine), despite the FDA lifting its ban on imports due to its potential as a coronavirus treatment.
-
Grifols teams up with US to test plasma therapy for Covid-19
pharmaceutical-technology
March 27, 2020
Spanish healthcare company Grifols has teamed up with the US Government agencies, including the Biomedical Advanced Research Development Authority (BARDA) ...
-
Mylan and Gilead waive exclusivity for potential Covid-19 therapies
pharmaceutical-technology
March 27, 2020
Mylan has waived its exclusive rights to generic Kaletra (lopinavir / ritonavir) in the US to aid wider access in case the medication would be effective Covid-19 therapies.